Search

Displaying results 6221 - 6230 of 10000 in total
  1. Drug

    Mentha arvensis top

    go.drugbank.com/drugs/DB14346
    Investigational

    Mentha arvensis top is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  2. Drug

    Apple fruit oil

    go.drugbank.com/drugs/DB14355
    Investigational

    Apple fruit oil is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  3. Drug

    Moringa oleifera leaf

    go.drugbank.com/drugs/DB14362
    Investigational

    Moringa oleifera leaf is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  4. Drug

    Capsicum annuum whole

    go.drugbank.com/drugs/DB14368
    Investigational

    Capsicum annuum whole is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  5. Drug

    Aspergillus niger var. niger

    go.drugbank.com/drugs/DB10426
    Approved

    Aspergillus niger var. niger extract is used in allergenic testing.

    Mixtures: Number Ten Mold Mixture, Number Ten Mold Mixture
  6. Drug

    Aureobasidium pullulans var. pullutans

    go.drugbank.com/drugs/DB10427
    Approved

    Aureobasidium pullulans var. pullutans extract is used in allergenic testing.

    Mixtures: Number Ten Mold Mixture, Number Ten Mold Mixture
  7. Drug

    Phoma exigua var. exigua

    go.drugbank.com/drugs/DB10440
    Approved

    Phoma exigua var. exigua extract is used in allergenic testing.

  8. Drug

    Alatrofloxacin

    go.drugbank.com/drugs/DB09335
    ApprovedWithdrawn

    It was withdrawn from the U.S. market in 2001.

  9. Drug

    Eutrema japonicum whole

    go.drugbank.com/drugs/DB14293
    Investigational

    Eutrema japonicum whole is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  10. Drug

    Ulimorelin

    go.drugbank.com/drugs/DB12128
    Investigational

    Ulimorelin is a novel small molecule ghrelin agonist being developed by Tranzyme Pharma as a first-in-class treatment for both POI and diabetic gastroparesis, serious medical conditions in which motility